Medical News

RSS

High dose B-vitamin therapy slows progression of diabetic nephropathy: Study

Patients with diabetic nephropathy (kidney disease caused by diabetes) who received high dose B-vitamin therapy experienced a more rapid decline in kidney function and had a higher rate of heart attack and stroke than patients who received placebo, according to a study in the April 28 issue of JAMA.

28 Apr 2010

Kaiser Permanente approves over 250 grants and donations totaling $7 million

Kaiser Permanente, one of America's leading health care providers and nonprofit health plans, announced today it approved more than 250 grants and donations nationwide totaling approximately $7 million in the first quarter of 2010. The grants focused on expanding access to nutritious food, providing safe spaces for all ages to increase physical activity, increasing opportunities for continuing education, and eliminating health disparities.

28 Apr 2010

Cancer-related expenditures increase faster than any other area of health care: JAMA

From 1999 through 2006 the use of diagnostic imaging for Medicare patients with cancer increased, with use of positron emission tomography increasing the most significantly, according to a study in the April 28 issue of JAMA. Imaging costs for these patients also increased, outpacing the rate of increase in total costs among Medicare beneficiaries with cancer.

28 Apr 2010

CTI receives positive reception from EMEA clinical experts for pixantrone MAA

Cell Therapeutics, Inc. today reported recent accomplishments and financial results for the first quarter ended March 31, 2010.

28 Apr 2010

Top ten tips for managing healthcare

America's healthcare system is about to undergo the most fundamental transformation in our nation's history. An already over-stressed system must absorb 32 million new patients at the same time that the country's huge baby boomer population is likely to need ever more medical attention as they age. And many of our most experienced and talented physicians will soon reach retirement age, leaving fewer experienced doctors to treat more patients.

28 Apr 2010

Study examines world-wide use of HSCT

An examination of the world-wide use of hematopoietic stem cell transplantation, which involves transplantation of blood stem cells derived from the bone marrow or blood, finds that there are significant differences in transplant rates between countries and continental regions by indication and donor type, and that HSCT is most frequently used in countries with higher gross national incomes and governmental health care expenditures, according to a study in the April 28 issue of JAMA.

28 Apr 2010

Potential new treatment for osteonecrosis

Researchers at Mount Sinai School of Medicine have found a potential new treatment for osteonecrosis, or the death of bone tissue, in people who are treated with steroids for several common medical conditions. There are currently no treatment options for people with this debilitating disease. The research is published in the April 27 issue of Proceedings of the National Academy of Sciences.

28 Apr 2010

BiondVax announces successful conclusion of second Phase I/II trial of Multimeric-001 Universal Flu Vaccine

BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of global efforts towards the development of a Universal Influenza Vaccine, announced the successful conclusion of the Company's second Phase I/II clinical trial of the Multimeric-001 Universal Influenza Vaccine.

28 Apr 2010

IMB awards manufacturer licenses to PPD’s Athlone facility

PPD, Inc. today announced its contract research facility in Athlone, Ireland, has been awarded manufacturer licenses by the Irish Medicines Board. The licenses support investigational medicinal products and marketed products and provide laboratory certifications for quality control of medicinal products.

28 Apr 2010

Causes of death in AIDS patients

New research shows that Antiretroviral Therapy (ART) continues to dramatically reduce rates of mortality from HIV infection in high-income countries, such that non-AIDS-related deaths exceed AIDS deaths after approximately four years of taking ART.

28 Apr 2010

Nu Skin Enterprises' revenue for first-quarter 2010 increases 23% to $364.1M

Nu Skin Enterprises, Inc. today announced record first-quarter results, with revenue of $364.1 million, a 23 percent improvement over the prior-year period. Quarterly revenue was positively impacted 8 percent by foreign currency fluctuations.

28 Apr 2010

Maryland startup Rhemisphere signs agreement with UMB for right to commercialize Blink system

Maryland startup Rhemisphere, LLC has licensed a unique, "all-in-one" patient monitoring system invented by clinical researchers at the University of Maryland, Baltimore.

28 Apr 2010

Pepscan reaches partnering agreement for therapeutic vaccine portfolio with Immunovo

Pepscan, the Netherlands based biotechnology firm focusing on protein mimicking technology for the generation of immune therapeutics, today announced that it reached a partnering agreement for its therapeutic vaccine portfolio with Immunovo BV of 's-Hertogenbosch. Under the terms of the agreement Pepscan will receive an undisclosed cash payment as well as a minority interest in Immunovo.

28 Apr 2010

Researchers participate in national multi-center trial comparing treatments for diabetic macular edema

A drug may be more effective against the leading cause of adult blindness than laser treatments, a new study has shown.

28 Apr 2010

State Round-up: Federal prosecutors investigate bid rigging at New York hospitals; Montana prepares for health reform implementation; and Florida spares Medicaid from budget cuts

The Wall Street Journal: "Federal prosecutors are investigating allegations that bid rigging and fraud at Mount Sinai Medical Center and New York-Presbyterian Hospital resulted in the hospitals awarding contracts worth tens of millions of dollars to outside contractors. Purchasing officials at the hospitals ... are alleged to have gotten more than a million dollars in payments from companies that were then given lucrative contracts to perform work such as re-insulating pipes and removing asbestos, according to documents filed in the Southern District of New York.

28 Apr 2010

Coronary artery calcium score helpful for determining intermediate risk of heart disease

Including a coronary artery calcium score in a risk assessment for future heart disease events, such as heart attacks, provides a better estimate in some populations than a standard coronary risk factors assessment, according to research supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

28 Apr 2010

Seattle Genetics reports revenues of $46.5M for first-quarter 2010

Seattle Genetics, Inc. today reported financial results for the first quarter ended March 31, 2010. The company also highlighted recent product development activities and planned milestones.

28 Apr 2010

Volcano to distribute AngioSculpt PTCA Scoring Balloon Catheter in Japan

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has entered into a distribution agreement with AngioScore for its AngioSculpt® PTCA Scoring Balloon Catheter for coronary indications in Japan. This is the first of what Volcano believes will be many products distributed by Volcano Japan, which now includes more than 50 direct sales representatives.

28 Apr 2010

Researchers develop new diagnostic approach to fight against Chagas disease

Chagas disease is one of the most deadly parasitic diseases in the world. It affects more than 10 million people, primarily in the Americas. In South America alone it kills 50 000 people each year. A reliable and rapid diagnosis is the key in the battle against infection but until now, this has been next to impossible.

28 Apr 2010

Trade negotiations between EU, India could affect access to low-cost generics

The Associated Press examines the ongoing free-trade negotiations between the EU and India - a country that according to PricewaterhouseCoopers currently "makes one-fifth of the world's generics." The negotiations "could make it harder for millions … across the developing world to get lifesaving drugs. The deal is taking shape as India tries to transform itself from a generics powerhouse into a base for drug discovery - a trend that could ultimately do more than any trade agreement to curtail its reign as a pharmacy to the poor."

28 Apr 2010

Medical News

High dose B-vitamin therapy slows progression of diabetic nephropathy: Study

Kaiser Permanente approves over 250 grants and donations totaling $7 million

Cancer-related expenditures increase faster than any other area of health care: JAMA

CTI receives positive reception from EMEA clinical experts for pixantrone MAA

Top ten tips for managing healthcare

Study examines world-wide use of HSCT

Potential new treatment for osteonecrosis

BiondVax announces successful conclusion of second Phase I/II trial of Multimeric-001 Universal Flu Vaccine

IMB awards manufacturer licenses to PPD’s Athlone facility

Causes of death in AIDS patients

Nu Skin Enterprises' revenue for first-quarter 2010 increases 23% to $364.1M

Maryland startup Rhemisphere signs agreement with UMB for right to commercialize Blink system

Pepscan reaches partnering agreement for therapeutic vaccine portfolio with Immunovo

Researchers participate in national multi-center trial comparing treatments for diabetic macular edema

State Round-up: Federal prosecutors investigate bid rigging at New York hospitals; Montana prepares for health reform implementation; and Florida spares Medicaid from budget cuts

Coronary artery calcium score helpful for determining intermediate risk of heart disease

Seattle Genetics reports revenues of $46.5M for first-quarter 2010

Volcano to distribute AngioSculpt PTCA Scoring Balloon Catheter in Japan

Researchers develop new diagnostic approach to fight against Chagas disease

Trade negotiations between EU, India could affect access to low-cost generics

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News